Kodiak Sciences Inc (KOD)
3.58
+0.05
(+1.42%)
USD |
NASDAQ |
May 02, 14:36
Kodiak Sciences Cash and Short Term Investments (Quarterly): 285.51M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 285.51M |
| September 30, 2023 | 345.67M |
| June 30, 2023 | 378.67M |
| March 31, 2023 | 421.19M |
| December 31, 2022 | 478.93M |
| September 30, 2022 | 537.40M |
| June 30, 2022 | 597.88M |
| March 31, 2022 | 671.73M |
| December 31, 2021 | 731.51M |
| September 30, 2021 | 799.25M |
| June 30, 2021 | 880.87M |
| March 31, 2021 | 928.98M |
| Date | Value |
|---|---|
| December 31, 2020 | 968.97M |
| September 30, 2020 | 380.45M |
| June 30, 2020 | 417.13M |
| March 31, 2020 | 421.86M |
| December 31, 2019 | 336.48M |
| September 30, 2019 | 60.60M |
| June 30, 2019 | 68.10M |
| March 31, 2019 | 81.08M |
| December 31, 2018 | 88.25M |
| September 30, 2018 | 11.59M |
| June 30, 2018 | 17.64M |
| December 31, 2017 | 1.395M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
60.60M
Minimum
Sep 2019
968.97M
Maximum
Dec 2020
511.11M
Average
421.86M
Median
Mar 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Avalo Therapeutics Inc | 7.415M |
| Regeneron Pharmaceuticals Inc | 10.84B |
| iBio Inc | 2.788M |
| Puma Biotechnology Inc | 95.94M |
| Dare Bioscience Inc | 10.48M |